call 1800 257 600 email [email protected]

Carney Complex

Carney complex is a rare type of multiple endocrine neoplasia syndromes (MENS) that is characterised by myxomas throughout the body, distinctive skin pigmentation and a predisposition to malignancy (cancer). Multiple endocrine neoplasia syndromes (MENS) are a rare group of neuroendocrine tumours characterised by tumours that develop in two or more endocrine glands. Endocrine glands are responsible for the production and secretion of hormones, and help to control many vital bodily functions

Neuroendocrine cancers are a complex group of tumours that develop in the neuroendocrine system, which is responsible for regulating important bodily functions such as heart rate, blood pressure and metabolism. They most commonly develop in the gastro-intestinal tract, pancreas, and the lungs; however, they can develop anywhere in the body. These tumours develop from neuroendocrine cells, which are responsible for receiving signals from the nervous system and producing hormones and peptides (small proteins) in response.

Familial cancer syndromes, also known as hereditary cancer syndromes, are rare conditions that cause an increased risk of cancer as the result of inherited genetic mutations in certain cancer-related genes. They can affect both adults and children, however they generally develop in people at a younger age than normal. While familial cancer syndromes are not classified as cancer, they are equally as severe and can be life-threatening as they are associated with the development of various tumours throughout the body. Having a familial cancer syndrome does not guarantee the development of cancer, however the risk of developing cancer is higher than those who do not have a familial cancer syndrome.

Carney complex is often confused with the conditions Carney-Stratakis syndrome (a rare condition that causes the development of paragangliomas and gastrointestinal stromal tumours (GISTs) only) and Carney triad (a very rare condition that causes the development of paragangliomas, GISTs, and pulmonary chondromas). While the three syndromes share a similar name, it is important to recognise they are different conditions. For more information on either Carney-Stratakis syndrome or Carney triad, please refer to their respective pages on the Rare Cancers Australia knowledgebase.

Carney complex tends to affect the sexes equally, and is generally diagnosed around the age of 20. However, anyone can develop this disease.

Carney complex is most commonly associated with the development of myxomas, however it has also been linked to other types of tumours. Some examples include:

Treatment

When cancers are detected, they are staged and graded based on size, metastasis, and how the cancer cells look under the microscope. Staging and grading helps your doctors determine the best treatment for you. However, each patient with Carney complex will present with a unique disease behaviour, with varying tumour locations and symptoms. As such, there is no one treatment method that will work for everyone, and there is no standard staging system for this disease. Instead of staging and grading, your doctor will recommend a treatment plan based on the following factors:

  • Type of tumours present.
  • Whether the tumours are malignant (cancerous) or benign (non-cancerous).
  • Tumour location.
  • Whether or not malignant tumours have metastasised.
  • Your age.
  • General health.
  • Your treatment preferences.

Your doctor may also recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. They will then discuss the most appropriate treatment option for you.

Treatment options for tumours associated with Carney complex may include:

  • Surgery to remove as much of the tumour(s) as possible – these will vary based on tumour type and location.
  • Chemotherapy.
  • Radiation therapy.
  • Clinical trials.
  • Palliative care.

Cancer Screening

Once a diagnosis of Carney complex has been confirmed, implementing a targeted screening plan becomes essential due to the increased risk of developing certain cancers.  The content of this plan will vary from person to person based on the genetic mutation involved, your family’s history of cancer and the types of cancers that may be present. It will also outline the routine tests you should have and how regularly you should have them.  Some recommendations for Carney complex may include:

  • Annual echocardiogram for cardiac myxomas in children and adults.
  • Annual thyroid ultrasound for thyroid nodules in children and adults.
  • Annual testicular ultrasound in males prior to puberty.
  • Annual endocrine studies beginning in adolescence, potentially including:
    • Cortisol.
    • Insulin-like growth factor-1 (IGF-1).
    • Prolactin.
  • Abdominal ultrasound at time of diagnosis in females.

Screening options for Carney complex may evolve as new technologies are developed and our understanding of the condition grows. It is essential to discuss your individual circumstances with your healthcare team to determine the most appropriate screening plan for you.

Risk factors

Carney complex is caused by a genetic mutation in the protein kinase A type-I alpha regulatory subunit (PRKAR1A) gene, which is responsible for promoting cell growth and division. It is an autosomal dominant disorder, which means you have a 50% chance of developing the condition if one of your parents carries the genetic mutation.

Symptoms

The symptoms of Carney complex often vary by the type(s) of tumours present. General symptoms of Carney complex may include:

  • Skin pigmentation on the face, lips, eyes, trunk, or genital mucosa.
  • Lentigines (small, raised spots that resemble freckles) on the skin.
  • Blue nevi on the skin.
  • Café-au-lait spots on the skin.
  • Fever.
  • Anaemia.
  • Unexplained weight loss/loss of appetite.
  • Joint stiffness.
  • Fatigue.

Symptoms related to specific tumours can be found on our knowledgebase.

Not everyone with the symptoms above will have cancer, but see your general practitioner (GP) if you are concerned.

Diagnosis

If your doctor suspects you have tumours associated with Carney complex, they may order some of the following tests to confirm the diagnosis and refer you to a specialist for treatment. The tests required for diagnosis will often vary based on the symptoms present, and where the tumour(s) are suspected to be located.

  • Physical examination.
  • Neurological examination.
  • Genetic testing.
  • Endocrine studies.
  • Imaging tests, potentially including:
    • Echocardiogram.
    • Ultrasound.
  • Electromyogram (EMG).
  • Nerve conduction studies.
  • Biopsy.

Biopsy and Testicular Cancer

After conducting the previously mentioned diagnostic tests, your doctor may strongly suspect that you have a testicular cancer. In most cases, a diagnosis can be confirmed after a biopsy, where a section of tissue is removed and analysed for cancer cells. However, doctors avoid conducting a biopsy in patients who have suspected testicular cancer as there is a small risk that making an incision in the scrotum could cause cancer cells to spread.  As such, the only way to confirm the diagnosis safely is to perform a unilateral orchidectomy (removal of one testicle).

Once the testicle has been removed, it will be sent to a laboratory and analysed for cancer cells.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.